NCT06675227

Brief Summary

Using Electrolyte Beverages as replacement for water to dissolve PEG(2L plan) in bowel preparation process. The aim of this study is to test whether Electrolyte Beverages as solvents can improve the cleanness of bowel preparation and the satisfaction of patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,766

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 3, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 5, 2024

Completed
6 days until next milestone

Study Start

First participant enrolled

November 11, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

March 20, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

November 3, 2024

Last Update Submit

March 17, 2025

Conditions

Keywords

bowel preparationElectrolyte Beverages

Outcome Measures

Primary Outcomes (1)

  • The Boston Bowel Preparation Scale

    The BBPS is a standardized 9-point assessment scale for the colon. The structure of the colon is divided into its three segments: right colon, transverse colon, and left colon. Each segment is classified from 0 to 3 depending on the degree of soiling. The sum total of the three segments represents the degree of soiling, so that a total ≤ 5 points shows poor bowel preparation, while 6-7 shows good bowel preparation, and ≥ 8 very good bowel preparation.

    From enrollment to the time point when patients finished colonscopy (within a week).

Secondary Outcomes (2)

  • The Palatability

    From enrollment to the time point when patients finished colonscopy(within a week).

  • Lesion Detection Rate

    From enrollment to the time point when patients finished colonscopy (within a week).

Other Outcomes (2)

  • Patient Willingness to Repeat

    From enrollment to the time point before colonscopy(within a week).

  • Bowel Preparation Time

    From enrollment to the time point before colonscopy(within a week).

Study Arms (2)

Drinking Water Group

NO INTERVENTION

This group will apply the ordinary drinking water as the solvents for 2L PEG to dissolve.

Electrolyte Beverages Group

EXPERIMENTAL

This group will apply the electrolyte beverages(Alienergy) instead of ordinary drinking water as the solvents for 2L PEG to dissolve.

Dietary Supplement: electrolyte beverages

Interventions

electrolyte beveragesDIETARY_SUPPLEMENT

Using Electrolyte Beverages as replacement for water to dissolve PEG(2L plan) in bowel preparation process.

Electrolyte Beverages Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy individuals or those with mild or well-controlled chronic diseases.
  • Patients scheduled for outpatient colonoscopy.
  • Patients prescribed sodium phosphate or polyethylene glycol for bowel preparation.
  • Willing to participate and sign the informed consent form.
  • Age ≥18 years
  • ECOG performance status \<2

You may not qualify if:

  • Patients who refuse to participate in the study.
  • Patients requiring enema preparation.
  • Uncontrolled hypertension.
  • Patients with diabetes.
  • Pregnant patients.
  • Suspected bowel obstruction.
  • Risk of aspiration.
  • Patients with severe ulcerative colitis, gastric retention, bowel perforation, toxic colitis, or megacolon.
  • Patients with severe systemic diseases (including NYHA class 3-4 heart failure, Child-Pugh class C liver failure).
  • Patients with a known allergy to polyethylene glycol.
  • Patients with a history of major gastrointestinal surgery or any other conditions that may interfere with study outcomes or adherence.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Army Medical Center

Chongqing, Chongqing Municipality, 400042, China

RECRUITING

Study Officials

  • Weidong Tong, MD

    Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

November 3, 2024

First Posted

November 5, 2024

Study Start

November 11, 2024

Primary Completion

December 30, 2025

Study Completion

December 31, 2025

Last Updated

March 20, 2025

Record last verified: 2025-03

Locations